| calcium channel, voltage-dependent, gamma subunit 5 |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
BOPINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
82% |
2.904uM |
2.824uM |
View
|
| Cytochrom P450-2D6 monooxygenase |
RITONAVIR |
CYP450-2D6 Inhibition |
82% |
50uM |
NoneNone |
View
|
| cholinergic receptor, muscarinic 3 |
OXICONAZOLE |
Muscarinic M3 |
82% |
4.531uM |
.9604uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
FLUORESCEIN |
CYP450-2C19 Inhibition |
82% |
.9074uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
OXYMETAZOLINE |
Adrenergic alpha2B |
82% |
1.273uM |
.581uM |
View
|
| adrenergic receptor, alpha 1a |
EBASTINE |
Adrenergic alpha1A |
82% |
2.6054uM |
1.0546uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
1,3-DIPHENYLGUANIDINE |
Adrenergic, Norepinephrine Transporter |
82% |
1.152uM |
1.143uM |
View
|
| histamine receptor H 2 |
PROMETHAZINE |
Histamine H2 |
82% |
1.165uM |
1.146uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
IVERMECTIN |
Adrenergic, Norepinephrine Transporter |
81% |
3.9475uM |
3.9149uM |
View
|
| prostaglandin-endoperoxide synthase 1 |
O-ANISIDINE |
Cyclooxygenase COX-1 |
81% |
3.152uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
O-ANISIDINE |
Cyclooxygenase COX-1 |
81% |
3.152uM |
NoneNone |
View
|
| Sigma-2 Receptor |
BUSPIRONE |
Sigma2 |
81% |
3.38uM |
2.08uM |
View
|
| adrenergic receptor, alpha 1b |
CLONIDINE |
Adrenergic alpha1B |
81% |
1.848uM |
1.023uM |
View
|
| thromboxane A synthase 1 |
ERGOTAMINE |
Thromboxane Synthetase |
81% |
3.064uM |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
ERGOTAMINE |
Thromboxane Synthetase |
81% |
3.064uM |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
CARBOXYMETHYLCELLULOSE |
Protein Serine/Threonine Kinase, ERK2 |
81% |
.216uM |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
CARBOXYMETHYLCELLULOSE |
Protein Serine/Threonine Kinase, ERK2 |
81% |
.216uM |
NoneNone |
View
|
| dopamine receptor D4 |
PROCHLORPERAZINE |
Dopamine D4.2 |
81% |
2.311uM |
.81uM |
View
|
| adrenergic receptor, alpha 2b |
DIMENHYDRINATE |
Adrenergic alpha2B |
81% |
5.457uM |
2.491uM |
View
|
| adrenergic receptor, alpha 2a |
CYPROHEPTADINE |
Imidazoline I2, Central |
81% |
1.307uM |
.871uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
CYPROHEPTADINE |
Imidazoline I2, Central |
81% |
1.307uM |
.871uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3a |
METOCLOPRAMIDE |
Serotonin 5-HT3 |
81% |
4.013uM |
.902uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3b |
METOCLOPRAMIDE |
Serotonin 5-HT3 |
81% |
4.013uM |
.902uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
MICONAZOLE |
Serotonin 5-HT2B |
81% |
5.545uM |
3.529uM |
View
|
| acetylcholinesterase (YT blood group) |
FENOFIBRATE |
Acetylcholinesterase |
81% |
15.551uM |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
FENOFIBRATE |
Acetylcholinesterase |
81% |
15.551uM |
NoneNone |
View
|
| acetylcholinesterase |
FENOFIBRATE |
Acetylcholinesterase |
81% |
15.551uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
DEXCHLORPHENIRAMINE |
Serotonin 5-HT2A |
81% |
3.692uM |
1.055uM |
View
|
| cholinergic receptor, muscarinic 1 |
DIETHYLSTILBESTROL |
Muscarinic M1 |
81% |
15.171uM |
3.654uM |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
BETA-ESTRADIOL 3-BENZOATE |
Glucocorticoid |
81% |
5.074uM |
2.306uM |
View
|
| Cytochrom P450-1A2 monooxygenase |
ALTRETAMINE |
CYP450-1A2 Inhibition |
81% |
4uM |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
3-ACETAMIDOPHENOL |
CYP450-1A2 Inhibition |
81% |
2uM |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
PYROGALLOL |
Protein Tyrosine Kinase, Fyn |
81% |
.997uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
AMOXAPINE |
Adrenergic alpha2C |
81% |
3.174uM |
.461uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
AMOXAPINE |
Adrenergic alpha2C |
81% |
3.174uM |
.461uM |
View
|
| Protein-tyrosine kinase, Fyn |
CHLORPROMAZINE |
Protein Tyrosine Kinase, Fyn |
81% |
8.68uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
AMIODARONE |
Adrenergic alpha2B |
81% |
12.893uM |
5.886uM |
View
|
| histamine receptor H 1 |
BETAMETHASONE PHOSPHATE |
Histamine H1, Central |
81% |
10.06uM |
1.169uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
BISACODYL |
Dopamine Transporter |
81% |
2.208uM |
1.755uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
PUROMYCIN |
Sodium Channel, Site 2 |
12% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
NIFEDIPINE |
Calcium Channel Type L, Benzothiazepine |
81% |
.00867uM |
.007707uM |
View
|
| potassium voltage-gated channel, subfamily H, member 8 |
TRIFLUOPERAZINE |
Potassium Channel HERG |
81% |
6.226uM |
5.1008uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 6 |
TRIFLUOPERAZINE |
Potassium Channel HERG |
81% |
6.226uM |
5.1008uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 7 |
TRIFLUOPERAZINE |
Potassium Channel HERG |
81% |
6.226uM |
5.1008uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 2 |
TRIFLUOPERAZINE |
Potassium Channel HERG |
81% |
6.226uM |
5.1008uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type I, beta |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type II, beta |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, nonvoltage-gated 1 beta |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type XI, alpha |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, nonvoltage-gated 1, delta |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type X, alpha |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type IX, alpha |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage gated, type VIII, alpha |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type VII, alpha |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
BW-723C86 |
Sodium Channel, Site 2 |
80% |
2.1739uM |
1.9833uM |
View
|
| tachykinin receptor 2 |
SULOCTIDIL |
Tachykinin NK2 |
80% |
6.7929uM |
2.2643uM |
View
|
| Protein-tyrosine kinase, Fyn |
ZINC CHLORIDE |
Protein Tyrosine Kinase, Fyn |
80% |
1.8779uM |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
ZINC CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
80% |
1.1003uM |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) |
ZINC CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
80% |
1.1003uM |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
ZINC CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
80% |
1.1003uM |
NoneNone |
View
|
| protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
ZINC CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
80% |
1.1003uM |
NoneNone |
View
|
| protein phosphatase 3, catalytic subunit, beta isoform |
ZINC CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
80% |
1.1003uM |
NoneNone |
View
|
| bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) |
ZINC CHLORIDE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
80% |
1.1003uM |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
NAFENOPIN |
Protein Serine/Threonine Kinase, ERK2 |
80% |
.8151uM |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
NAFENOPIN |
Protein Serine/Threonine Kinase, ERK2 |
80% |
.8151uM |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
PERHEXILINE |
Muscarinic M1 |
80% |
2.7105uM |
.6528uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PERHEXILINE |
Calcium Channel Type L, Phenylalkylamine |
80% |
1.3499uM |
1.3124uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
PERHEXILINE |
Calcium Channel Type L, Phenylalkylamine |
80% |
1.3499uM |
1.3124uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
PERHEXILINE |
Calcium Channel Type L, Phenylalkylamine |
80% |
1.3499uM |
1.3124uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
PERHEXILINE |
Calcium Channel Type L, Phenylalkylamine |
80% |
1.3499uM |
1.3124uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
PERHEXILINE |
Calcium Channel Type L, Phenylalkylamine |
80% |
1.3499uM |
1.3124uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
PERHEXILINE |
Calcium Channel Type L, Phenylalkylamine |
80% |
1.3499uM |
1.3124uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
PERHEXILINE |
Calcium Channel Type L, Phenylalkylamine |
80% |
1.3499uM |
1.3124uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
RESERPINE |
Calcium Channel Type L, Benzothiazepine |
79% |
3.707uM |
3.295uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
RESERPINE |
Calcium Channel Type L, Benzothiazepine |
79% |
3.707uM |
3.295uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
RESERPINE |
Calcium Channel Type L, Benzothiazepine |
79% |
3.707uM |
3.295uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
RESERPINE |
Calcium Channel Type L, Benzothiazepine |
79% |
3.707uM |
3.295uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
RESERPINE |
Calcium Channel Type L, Benzothiazepine |
79% |
3.707uM |
3.295uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
RESERPINE |
Calcium Channel Type L, Benzothiazepine |
79% |
3.707uM |
3.295uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
RESERPINE |
Calcium Channel Type L, Benzothiazepine |
79% |
3.707uM |
3.295uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
RESERPINE |
Calcium Channel Type L, Benzothiazepine |
79% |
3.707uM |
3.295uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
RESERPINE |
Calcium Channel Type L, Benzothiazepine |
79% |
3.707uM |
3.295uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
VALDECOXIB |
Adrenergic, Norepinephrine Transporter |
82% |
2.927uM |
2.903uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
ALFACALCIDOL |
Adrenergic, Norepinephrine Transporter |
82% |
1.009uM |
1uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
SB-203580 |
CYP450-2C19 Inhibition |
82% |
.8uM |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
SB-203580 |
Adenosine Transporter |
82% |
5.923uM |
2.026uM |
View
|
| concentrative Na+ nucleoside cotransporter (DBSS) |
SB-203580 |
Adenosine Transporter |
82% |
5.923uM |
2.026uM |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
SB-203580 |
Adenosine Transporter |
82% |
5.923uM |
2.026uM |
View
|
| adenine nucleotide translocase (DBSS) (Non-specific probe) |
SB-203580 |
Adenosine Transporter |
82% |
5.923uM |
2.026uM |
View
|
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
SB-203580 |
Adenosine Transporter |
82% |
5.923uM |
2.026uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
PROPOFOL |
Serotonin 5-HT2B |
82% |
5.499uM |
3.499uM |
View
|
| dopamine receptor 2 |
DROPERIDOL |
Dopamine D2L |
82% |
.002407uM |
.000802uM |
View
|
| adrenergic receptor, alpha 2a |
DROPERIDOL |
Imidazoline I2, Central |
82% |
2.854uM |
1.903uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
DROPERIDOL |
Imidazoline I2, Central |
82% |
2.854uM |
1.903uM |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
DISULFIRAM |
Adenosine Transporter |
82% |
16.918uM |
5.788uM |
View
|
| concentrative Na+ nucleoside cotransporter (DBSS) |
DISULFIRAM |
Adenosine Transporter |
82% |
16.918uM |
5.788uM |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
DISULFIRAM |
Adenosine Transporter |
82% |
16.918uM |
5.788uM |
View
|
| adenine nucleotide translocase (DBSS) (Non-specific probe) |
DISULFIRAM |
Adenosine Transporter |
82% |
16.918uM |
5.788uM |
View
|
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
DISULFIRAM |
Adenosine Transporter |
82% |
16.918uM |
5.788uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
AMITRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
82% |
1.992uM |
1.771uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
AMITRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
82% |
1.992uM |
1.771uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
AMITRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
82% |
1.992uM |
1.771uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
AMITRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
82% |
1.992uM |
1.771uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
AMITRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
82% |
1.992uM |
1.771uM |
View
|
| mitogen-activated protein kinase 3 |
1-NAPHTHYL ISOTHIOCYANATE |
Protein Serine/Threonine Kinase, ERK1 |
45% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
AMITRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
82% |
1.992uM |
1.771uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
AMITRIPTYLINE |
Calcium Channel Type L, Benzothiazepine |
82% |
1.992uM |
1.771uM |
View
|
| mitogen activated protein kinase 3 |
U-78517F |
Protein Serine/Threonine Kinase, ERK1 |
82% |
4.962uM |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
U-78517F |
Protein Serine/Threonine Kinase, ERK1 |
82% |
4.962uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
CHLORPROMAZINE |
Imidazoline I2, Central |
82% |
2.671uM |
1.781uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
CHLORPROMAZINE |
Imidazoline I2, Central |
82% |
2.671uM |
1.781uM |
View
|
| tachykinin receptor 2 |
AMIODARONE |
Tachykinin NK2 |
82% |
19.315uM |
6.438uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
LOVASTATIN |
Dopamine Transporter |
82% |
10.104uM |
8.028uM |
View
|
| prostaglandin-endoperoxide synthase 2 |
ZOMEPIRAC |
Cyclooxygenase COX-2 |
82% |
1.113uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
ZOMEPIRAC |
Cyclooxygenase COX-2 |
82% |
1.113uM |
NoneNone |
View
|
| cholinergic receptor, muscarinic 3 |
BETAMETHASONE PHOSPHATE |
Muscarinic M3 |
82% |
6.429uM |
1.363uM |
View
|
| thromboxane A synthase 1 |
TROVAFLOXACIN |
Thromboxane Synthetase |
82% |
4.023uM |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
TROVAFLOXACIN |
Thromboxane Synthetase |
82% |
4.023uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
TERAZOSIN |
Imidazoline I2, Central |
82% |
1.269uM |
.846uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
TERAZOSIN |
Imidazoline I2, Central |
82% |
1.269uM |
.846uM |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
TAMOXIFEN |
ATPase, Na+/K+ |
82% |
15.611uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
TAMOXIFEN |
ATPase, Na+/K+ |
82% |
15.611uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
TAMOXIFEN |
ATPase, Na+/K+ |
82% |
15.611uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
TAMOXIFEN |
ATPase, Na+/K+ |
82% |
15.611uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
TAMOXIFEN |
ATPase, Na+/K+ |
82% |
15.611uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
TAMOXIFEN |
ATPase, Na+/K+ |
82% |
15.611uM |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
TAMOXIFEN |
ATPase, Na+/K+ |
82% |
15.611uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
TAMOXIFEN |
ATPase, Na+/K+ |
82% |
15.611uM |
NoneNone |
View
|
| mu-opioid receptor MOR |
TAMOXIFEN |
Opiate mu |
82% |
17.594uM |
7.142uM |
View
|
| mitogen activated protein kinase 3 |
THIMEROSAL |
Protein Serine/Threonine Kinase, ERK1 |
82% |
.774uM |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
THIMEROSAL |
Protein Serine/Threonine Kinase, ERK1 |
82% |
.774uM |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
THIMEROSAL |
Serotonin 5-HT6 |
82% |
5.937uM |
2.756uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
FLUPHENAZINE |
Calcium Channel Type L, Benzothiazepine |
82% |
8.618uM |
7.66uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
FLUPHENAZINE |
Calcium Channel Type L, Benzothiazepine |
82% |
8.618uM |
7.66uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 5 |
TRIFLUOPERAZINE |
Potassium Channel HERG |
81% |
6.226uM |
5.1008uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 3 |
TRIFLUOPERAZINE |
Potassium Channel HERG |
81% |
6.226uM |
5.1008uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 4 |
TRIFLUOPERAZINE |
Potassium Channel HERG |
81% |
6.226uM |
5.1008uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
TRIFLUOPERAZINE |
Potassium Channel HERG |
81% |
6.226uM |
5.1008uM |
View
|
| potassium voltage-gated channel, subfamily H (eag-related), member 1 |
TRIFLUOPERAZINE |
Potassium Channel HERG |
81% |
6.226uM |
5.1008uM |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
GENTIAN VIOLET |
CYP450-3A4 Inhibition |
81% |
3.6337uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
BW-723C86 |
Calcium Channel Type L, Phenylalkylamine |
81% |
4.3383uM |
4.2178uM |
View
|